13G Filing: Aisling Capital IV, LP and GTx Inc (GTXI)

Page 9 of 11

Page 9 of 11 – SEC Filing

CUSIP No.  40052B 20 7
SCHEDULE 13G
Page 10 of 12
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated:  October 5, 2017
AISLING CAPITAL IV, LP
By: Aisling Capital Partners IV, LP,
As its General Partner
By: Aisling Capital Partners IV LLC,
As its General Partner
By:
/s/ Andrew Schiff
Name: Andrew Schiff
Title:   Managing Member
AISLING CAPITAL PARTNERS IV, LP
By: Aisling Capital Partners IV LLC,
As its General Partner
By:
/s/ Andrew Schiff
Name: Andrew Schiff
Title:   Managing Member
AISLING CAPITAL PARTNERS IV LLC
By:
/s/ Andrew Schiff
Name: Andrew Schiff
Title:   Managing Member
STEVE ELMS
By:
/s/ Steve Elms
ANDREW SCHIFF
By:
/s/ Andrew Schiff

Follow Oncternal Therapeutics Inc. (NASDAQ:ONCT)

Page 9 of 11